EREG is usually overexpressed in several human cancers including bladder, brain, breast, colorectal and lung cancer and it is used as a predictive biomarker i.e. in metastatic colorectal cancer (13, 28). The gene discussed is EREG; the disease is metastatic colorectal cancer.